Parviz ShamlouVice President & Executive Director at Thomas Jefferson University | Jefferson Institute for Bioprocessing
Parviz is a chemical engineer with 37 years of academic and industry experience in bioprocessing with the focus on biopharmaceutical and biologic process development. Parviz spent 20 years UCL and 11 years at Eli Lilly where he worked on process design, development, evaluation, implementation, tech transfer to GMP manufacturing, new technology evaluation, and first principle modeling. He has worked on a variety of molecules including monoclonal antibodies, fusion proteins, Pegylated proteins and mAb fragments. Over the past decade, his interest has extended into the bioprocessing of cell and gene therapies, viral vectors, and next generation vaccines.